Pangaea Oncology, S.A. (BME:PANG)

Pangaea Oncology Revenue

In the year 2025, Pangaea Oncology had annual revenue of 16.73M EUR, down -0.32%. Pangaea Oncology had revenue of 7.55M in the half year ending June 30, 2024, with 124.19% growth.

• Revenue: 16.73M
• Revenue Growth: +68.10%
• P/S Ratio: 3.31
• Revenue / Employee: 101.42K
• Employees: 159
• Market Cap: 55.31M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	16.73M	-53.52K	-0.32%
Dec 31, 2024	16.79M	6.83M	68.64%
Dec 31, 2023	9.95M	3.28M	49.12%
Dec 31, 2022	6.68M	-32.46K	-0.48%
Dec 31, 2021	6.71M	531.99K	8.61%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2024

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 18, 2026

Data Sources Report a data error